DocDollars

Becton, Dickinson and Company

NJ · United States · Reporting entity ID 100000005485

Total reported 2019–2025
$119.5M
#83 of 2,960 reporting companies — 0.1% of all reported industry payments
$41.7M in general payments across 48,477 records, plus $77.8M in research funding across 1,332 records.

How it breaks down

General payments $41,710,954
Research funding $77,812,374

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Becton, Dickinson and Company reported $119.5M to US doctors and teaching hospitals from 2019 to 2025, ranking #83 of 2,960 reporting companies. 65% of that was research funding and 35% general payments such as consulting, speaking, food and travel. 48,477 general payment records and 1,332 research records were filed.

Common questions about Becton, Dickinson and Company

How much has Becton, Dickinson and Company paid US doctors?

Becton, Dickinson and Company reported $119,523,328 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $41,710,954 in general payments, $77,812,374 in research funding.

How does Becton, Dickinson and Company rank among drug and device companies?

It ranks #83 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Becton, Dickinson and Company mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.